Application and Research Progress of Carbonated Hydroxyapatite in Bone Tissue Regeneration
Advanced Biology · 2026
DOI: 10.1002/adbi.202500451 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Biology, 2026. Verfasst von Yifu Bian und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, School and Hospital of Stomatology, Jilin University, Changchun, China. Hauptthemen laut MEDLINE: Bone Regeneration, Durapatite, Tissue Engineering, Bone and Bones. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 115 Literaturangaben. Gefördert von: Natural Science Fund of China, National Center for Medical Education Development, Science and Technology Project of Jilin Province Department of Finance.
Abstract (Originalsprache)
Carbonated Hydroxyapatite (CHA) has attracted widespread attention in bone tissue regeneration due to its chemical composition and crystal structure, which are similar to natural bone tissue. This review summarizes the basic characteristics of CHA, preparation methods, and advances in its application in bone repair. First, the crystal structure, chemical composition, and the effect of carbonate doping on its physicochemical properties are discussed, focusing on how preparation techniques such as the wet chemical method, sol–gel method, and hydrothermal synthesis regulate CHA's properties. Second, the biological mechanisms of CHA in bone tissue regeneration are outlined, including its role in promoting osteoblast proliferation and differentiation, regulating the bone repair microenvironment, and mediating related signaling pathways (e.g., Wnt/β‐catenin and bone morphogenetic protein (BMP)/Smad). Furthermore, the research progress of CHA in repairing cranial, alveolar, and long bone defects is systematically reviewed through animal models and clinical studies to evaluate its bone repair capacity and biocompatibility. In addition, the composite application of CHA with polymers and bioactive glass and its potential development in frontier technologies such as 3D printing and smart drug delivery are discussed. Finally, the challenges in mechanical properties, degradation rate, and preparation processes are analyzed, and the future application prospects of CHA as an intelligent, multifunctional bone repair material are envisaged. This review aims to provide theoretical support and research insights to optimize the design and application of CHA in bone tissue engineering.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Surgery, School and Hospital of Stomatology, Jilin University, Changchun, China.
- Jilin Provincial Key Laboratory of Oral and Craniofacial Diseases & Tissue Reconstruction, Jilin University, Changchun, China.
Förderung
- Natural Science Fund of China
- National Center for Medical Education Development
- Science and Technology Project of Jilin Province Department of Finance
- Bethune College of Medicine of Jilin University
- Postgraduate Plan of Jilin University
- Postgraduate Education and Teaching Reform Research of Jilin University
- Innovation and Entrepreneurship Program for College Students of Jilin University
- Special Project on AI-Empowered Undergraduate Education and Teaching Reform of Jilin University
Zitieren
APA
Bian, Y., Duan, X., Han, S., Yuan, Y., Shen, J., Wang, Z., & Han, B. (2026). Application and Research Progress of Carbonated Hydroxyapatite in Bone Tissue Regeneration. Advanced Biology. https://doi.org/10.1002/adbi.202500451
Vancouver
Bian Y, Duan X, Han S, Yuan Y, Shen J, Wang Z, et al. Application and Research Progress of Carbonated Hydroxyapatite in Bone Tissue Regeneration. Advanced Biology. 2026. doi:10.1002/adbi.202500451
BibTeX
@article{Bian2026,
author = {Bian, Yifu and Duan, Xinliang and Han, Sichen and Yuan, Yao and Shen, Jiayu and Wang, Zilin and Han, Bing},
title = {Application and Research Progress of Carbonated Hydroxyapatite in Bone Tissue Regeneration},
journal = {Advanced Biology},
year = {2026},
doi = {10.1002/adbi.202500451}
}
EUVIMED